Related Experiment Video
Updated: May 17, 2025
Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity
Qing Zhou1, Markus D Siegelin1, Lloyd A Greene1
1Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA.
Abstract:
Natural killer (NK) cells are an important innate defense against malignancies, and exogenous sources of NK cells have been developed as anti-cancer agents. Nevertheless, the apparent limitations of NK cells in clearing cancers have suggested that their efficacy might be augmented by combination with other treatments. We have developed cell-penetrating peptides that target the transcription factors ATF5, CEBPB, and CEBPD and that promote apoptotic cancer cell death both in vitro and in vivo without apparent toxicity to non-transformed cells. We report here that one such peptide, Dpep, significantly sensitizes a variety of tumor cell types to the cytotoxic activity of the NK cell line, NK-92MI. Such sensitization requires pre-exposure of tumor cells to Dpep and does not appear due to effects of Dpep on NK cells themselves. Our findings suggest that Dpep acts in this context to lower the apoptotic threshold of tumor cells to NK cell toxicity. Additionally, while Dpep pre-treatment does not prevent tumor cells from causing NK cell "inactivation", it sensitizes cancer cells to repeated rounds of exposure to fresh NK cells. These findings thus indicate that Dpep pre-treatment is an effective strategy to sensitize cancer cells to the cytotoxic actions of NK cells.
Insights
This study shows that a peptide called Dpep sensitizes cancer cells to natural killer (NK) cell therapy. Pre-treating tumors with Dpep enhances NK cell effectiveness against malignancies.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Therapeutics
Background:
- Natural killer (NK) cells are crucial for innate immunity against cancer.
- Limitations in NK cell efficacy necessitate combination therapies for improved anti-cancer activity.
- Cell-penetrating peptides targeting transcription factors offer a novel therapeutic approach.
Purpose of the Study:
- To investigate the potential of cell-penetrating peptides to augment NK cell-based cancer immunotherapy.
- To evaluate the efficacy of a specific peptide, Dpep, in sensitizing tumor cells to NK cell cytotoxicity.
- To elucidate the mechanism by which Dpep enhances NK cell activity.
Main Methods:
- Development of cell-penetrating peptides targeting transcription factors ATF5, CEBPB, and CEBPD.
- In vitro and in vivo assessment of Dpep's effect on cancer cell apoptosis.
- Evaluation of Dpep's impact on the sensitization of tumor cells to NK-92MI (a human NK cell line) cytotoxicity.
- Analysis of Dpep's effect on NK cell inactivation and tumor cell response to repeated NK cell exposure.
Main Results:
- Dpep promotes apoptotic cancer cell death without toxicity to non-transformed cells.
- Pre-exposure to Dpep significantly sensitizes various tumor cell types to NK-92MI cytotoxic activity.
- Dpep's sensitization effect is attributed to lowering the apoptotic threshold of tumor cells, not altering NK cell function.
- Dpep pre-treatment enables cancer cells to be sensitive to repeated NK cell treatments.
Conclusions:
- Dpep is a promising therapeutic agent for enhancing NK cell-mediated cancer therapy.
- Dpep pre-treatment represents an effective strategy to overcome NK cell limitations in cancer treatment.
- The findings support the development of Dpep as an adjunct therapy to boost NK cell immunotherapy efficacy.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...